Biggest News Aggregation in the World
📰 Dose Dependent Reduction News

Dose Dependent Reduction News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Dose Dependent Reduction. Real-time updates on events, politics, business and more.

Aeglea BioTherapeutics Announces Interim Results from Ongoing Phase 1/2 Clinical Trial of Pegtarviliase for the Treatment of Classical Homocystinuria and Begins Process to Explore Strategic Alternatives

Results from Cohorts 1 and 2 Showed a Dose-Dependent Reduction in Total Homocysteine Levels Results from Cohort 3 Indicated Additional Dose Exploration and Data from Longer Treatment Duration May... | April 12, 2023
United States Linda Neuman Aeglea Biotherapeutics Jeffrey Goldberg Cortney Caudill Michaelc Hanley

CinCor Pharma Announces Late-Breaking Presentation of Phase 2 BrigHtn Data on Baxdrostat in Treatment-Resistant Hypertension at the 2022 American Heart Association Scientific Sessions

Aldosterone and renin biomarker activity clinically demonstrate how baxdrostat mechanistically achieves selective blood pressure lowering effects with no impact on cortisol
United States Mason Freeman American Heart Association Cincor Pharma Inc Cincor Pharma Heart Association

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science